论文信息 - Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis Type 1 Cohort with Tibial Pseudarthrosis. - 字舞流文

Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis Type 1 Cohort with Tibial Pseudarthrosis.

J. Carey | R. Margraf | D. Viskochil | D. Stevenson | J. D’Astous | H. Hanson | R. Mao | David W Sant | D. Sant | Chad VanSant-Webb | Heather Hanson

[1] R. Margraf,et al. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1 , 2015, Journal of Medical Genetics.

[2] C. Wise,et al. Neurofibromin Deficiency‐Associated Transcriptional Dysregulation Suggests a Novel Therapy for Tibial Pseudoarthrosis in NF1 , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3] Karl V. Voelkerding,et al. VarBin, a novel method for classifying true and false positive variants in NGS data , 2013, BMC Bioinformatics.

[4] A. Crawford,et al. Approaches to Treating NF1 Tibial Pseudarthrosis: Consensus From the Children’s Tumor Foundation NF1 Bone Abnormalities Consortium , 2013, Journal of pediatric orthopedics.

[5] Jason Li,et al. CONTRA: copy number analysis for targeted resequencing , 2012, Bioinform..

[6] Tatiana Popova,et al. Supplementary Methods , 2012, Acta Neuropsychiatrica.

[7] Emmanuel Barillot,et al. Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization , 2010, Bioinform..

[8] S. Mundlos,et al. Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options , 2009, American journal of medical genetics. Part A.

[9] J. Carey,et al. Double inactivation of NF1 in tibial pseudarthrosis. , 2006, American journal of human genetics.